Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Percy

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Blood|November 8, 2003
The worldwide distribution of the VHL 598C>T mutation indicates a single founding eventEnli Liu, Melanie J Percy, Christopher I Amos, et al.
European Journal of Haematology|May 8, 2015
Molecular diagnostics of myeloproliferative neoplasmsStephen E Langabeer, Hajnalka Andrikovics, Julia Asp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2020
Tibetan <i>PHD2</i>, an allele with loss-of-function propertiesDaisheng Song, Bradleigh E Navalsky, Wei Guan, et al.
American Journal of Hematology|February 28, 2012
Two new mutations in the HIF2A gene associated with erythrocytosisMelanie J Percy, Yu Jin Chung, Claire Harrison, et al.
Plos Medicine|June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiologyThomas G Smith, Jerome T Brooks, George M Balanos, et al.
Advances in Experimental Medicine and Biology|December 19, 2007
Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiologyT G Smith, J T Brooks, G M Balanos, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutationFederico Formenti, Philip A Beer, Quentin P P Croft, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Regulation of human metabolism by hypoxia-inducible factorFederico Formenti, Dumitru Constantin-Teodosiu, Yaso Emmanuel, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Blood|November 8, 2003
The worldwide distribution of the VHL 598C>T mutation indicates a single founding eventEnli Liu, Melanie J Percy, Christopher I Amos, et al.
European Journal of Haematology|May 8, 2015
Molecular diagnostics of myeloproliferative neoplasmsStephen E Langabeer, Hajnalka Andrikovics, Julia Asp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2020
Tibetan <i>PHD2</i>, an allele with loss-of-function propertiesDaisheng Song, Bradleigh E Navalsky, Wei Guan, et al.
American Journal of Hematology|February 28, 2012
Two new mutations in the HIF2A gene associated with erythrocytosisMelanie J Percy, Yu Jin Chung, Claire Harrison, et al.
Plos Medicine|June 14, 2006
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiologyThomas G Smith, Jerome T Brooks, George M Balanos, et al.
Advances in Experimental Medicine and Biology|December 19, 2007
Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiologyT G Smith, J T Brooks, G M Balanos, et al.
Blood|March 23, 2010
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasmsAmy V Jones, Peter J Campbell, Philip A Beer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2011
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutationFederico Formenti, Philip A Beer, Quentin P P Croft, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Regulation of human metabolism by hypoxia-inducible factorFederico Formenti, Dumitru Constantin-Teodosiu, Yaso Emmanuel, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
Pageof 18